Confluence Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-15,163
Closed -$2.69M 306
2020
Q1
$2.69M Sell
15,163
-159,001
-91% -$29.9M 0.05% 169
2019
Q4
$29.2M Buy
174,164
+19,645
+13% +$3.54M 0.47% 57
2019
Q3
$26M Sell
154,519
-19,645
-11% -$3.2M 0.41% 66
2019
Q2
$29.2M Buy
174,164
+5,523
+3% +$765K 0.47% 57
2019
Q1
$24.7M Buy
168,641
+17,396
+12% +$2.52M 0.42% 59
2018
Q4
$20.2M Sell
151,245
-184,610
-55% -$30.3M 0.38% 66
2018
Q3
$64M Sell
335,855
-19,994
-6% -$3.67M 1.09% 34
2018
Q2
$59.3M Sell
355,849
-8,375
-2% -$1.34M 1.04% 35
2018
Q1
$61.3M Buy
364,224
+24,093
+7% +$4.04M 1.13% 35
2017
Q4
$55.6M Buy
340,131
+21,245
+7% +$3.81M 1.02% 37
2017
Q3
$65.4M Buy
318,886
+23,491
+8% +$5.46M 1.25% 35
2017
Q2
$71.8M Buy
295,395
+29,058
+11% +$6.83M 1.46% 31
2017
Q1
$63.6M Buy
266,337
+18,219
+7% +$4.24M 1.42% 29
2016
Q4
$52.1M Buy
248,118
+133,880
+117% +$27.7M 1.26% 34
2016
Q3
$26.3M Buy
+114,238
New +$27.9M 0.69% 51

Other funds holding AGN

Confluence Investment Management's AGN Position: Q2 2020 in Review

Confluence Investment Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 15,163 shares — an estimated $2.69M sold.

Confluence Investment Management first reported a position in AGN in Q3 2016 and held it in 15 quarters. The position peaked at $71.8M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Confluence Investment Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Confluence Investment Management sold 15,163 Allergan plc shares in Q2 2020, an estimated $2.69M.
  • Confluence Investment Management first reported a position in Allergan plc in Q3 2016 and held it in 15 quarters.
  • Confluence Investment Management's Allergan plc position peaked at $71.8M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Confluence Investment Management's 13F filing for Q2 2020, filed 1 Jul 2020.